Back to results
US 2017/0281636 A1Published application
Antiviral therapy
AssigneeViiV Healthcare Company
InventorMark Richard UNDERWOOD
Life of this patent
Estimating the term…
Abstract
The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
Claims16
A method of treating HIV infection by administering to a subject the compound of formula (I)
- or a pharmaceutically acceptable salt thereof, with a therapeutic agent that is the active ingredient tenofovir in the subject.
A pharmaceutical composition comprising a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, with a therapeutic agent that is the active ingredient tenofavir in the subject.
A combination comprising as active ingredients, the compound of formula (I),
- or a pharmaceutically acceptable salt thereof, tenofovir, and a nucleoside reverse transcriptase inhibitor.
A combination comprising as active ingredients 20-300 mg of the compound of formula (I),
- or a pharmaceutically acceptable salt thereof, 20-300 of tenofovir, and 20-300 mg of a nucleoside reverse transcriptase inhibitor.
Dependencies are inferred from the claim text.